Skip to main content
Equibles

DIMENSIONAL FUND ADVISORS LP

Position in VIR — Vir Biotechnology, Inc.

CIK 354204 AUSTIN, TX
Back to VIR Full portfolio

Position in VIR

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$31,786,898
+$8,672,985 QoQ
Shares Held
3,119,421
+20.9% QoQ
Ownership
1.84%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#10
of 237 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 89% Shared 6% None 4%

Common Shares in VIR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DIMENSIONAL FUND ADVISORS LP holds $6,163,799,259 across 230 Biotechnology names. VIR ranks #46 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,168,956 $580,655,511
2 JAZZ
Jazz Pharmaceuticals plc
 1,713,592 $412,924,262
3 REGN
Regeneron Pharmaceuticals, Inc.
 559,687 $348,987,230
4 INCY
Incyte Corp
 2,280,803 $258,551,825
5 EXEL
Exelixis, Inc.
 4,426,620 $240,852,392
6 BMRN
Biomarin Pharmaceutical Inc
 4,075,714 $233,212,353
7 ROIV
Roivant Sciences Ltd.
 5,230,417 $185,104,455
8 KRYS
Krystal Biotech, Inc.
 476,038 $176,929,041

All Filings in VIR

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $31,786,898 3,119,421
2026-03-31 $23,113,913 2,579,678
2025-12-31 $15,293,748 2,536,277
2025-09-30 $17,009,352 2,978,871
2025-06-30 $15,160,091 3,007,955
2025-03-31 $17,395,007 2,684,415
2024-12-31 $14,059,511 1,915,465
2024-09-30 $9,078,665 1,212,105
2024-06-30 $5,673,624 637,486
2024-03-31 $5,866,544 579,126
2023-12-31 $4,711,287 468,319
2023-09-30 $6,817,751 727,615
2023-06-30 $25,087,786 1,022,739
2023-03-31 $1,049,477 45,100
2022-12-31 $1,141,481 45,100
2022-09-30 $869,528 45,100
2022-06-30 $2,989,641 117,379
2022-03-31 $15,749,281 612,336
2021-12-31 $13,421,470 320,551
2021-09-30 $2,240,496 51,482
2021-06-30 $1,781,935 37,689
2021-03-31 $2,464,548 48,070
2020-12-31 $264,318 9,870
2020-09-30 $329,430 9,596